先进制造业知识服务平台
国家科技图书文献中心机械分馆  工信部产业技术基础公共服务平台  国家中小企业公共服务示范平台

OA期刊


ISSN1942-0862
刊名Mabs
出版商Taylor & Francis Inc.
urlhttps://www.tandfonline.com/loi/kmab20
机构Taylor & Francis Ltd.



全部

2010 2011 2012 2013 2014 2015
2016 2017 2018 2019 2020 2021
2022 2023 2024 2025

2022, vol.14, no.1

题名作者出版年年卷期
Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodiesRahmad Akbar;Habib Bashour;Puneet Rawat;Philippe A.Robert;Eva Smorodina;Tudor-Stefan Cotet;Karine Flem-Karlsen;Robert Frank;Brij Bhushan Mehta;Mai Ha Vu;Talip Zengin;Jose Gutierrez-Marcos;Fridtjof Lund-Johansen;Jan Terje Andersen;Victor Greiff;20222022, vol.14, no.1
Enzymatic glycan remodeling–metal free click (GlycoConnect™) provides homogenous antibody-drug conjugates with improved stability and therapeutic index without sequence engineeringMarloes A.Wijdeven;Remon van Geel;Jorin H.Hoogenboom;Jorge M.M.Verkade;Brian M.G.Janssen;Inge Hurkmans;Laureen de Bever;Sander S.van Berkel;Floris L.van Delft;20222022, vol.14, no.1
Discovery and engineering of an anti-TREM2 antibody to promote amyloid plaque clearance by microglia in 5XFAD micePeng Zhao;Yuanzhong Xu;Xuejun Fan;Leike Li;Xin Li;Hisashi Arase;Qingchun Tong;Ningyan Zhang;Zhiqiang An;20222022, vol.14, no.1
A computational method for predicting the aggregation propensity of IgG1 and IgG4(P) mAbs in common storage buffersJames T.Heads;Sebastian Kelm;Kerry Tyson;Alastair D.G.Lawson;20222022, vol.14, no.1
Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage librariesTom Z.Yuan;Pankaj Garg;Linya Wang;Jordan R.Willis;Eric Kwan;Ana G Lujan Hernandez;Emily Tuscano;Emily N.Sever;Erica Keane;Cinque Soto;Eric M.Mucker;Mallorie E.Fouch;Edgar Davidson;Benjamin J.Doranz;Shweta Kailasan;M.Javad Aman;Haoyang Li;Jay W.Hooper;Erica Ollmann Saphire;James E.Crowe;Qiang Liu;Fumiko Axelrod;Aaron K.Sato;20222022, vol.14, no.1
Therapeutic antibodies for COVID-19: is a new age of IgM, IgA and bispecific antibodies coming?Jingjing Zhang;Han Zhang;Litao Sun;20222022, vol.14, no.1
Engineering a pure and stable heterodimeric IgA for the development of multispecific therapeuticsFlorian Heinkel;Meghan M.Verstraete;Siran Cao;Janessa Li;Patrick Farber;Elizabeth Stangle;Begonia Silva-Moreno;Fangni Peng;Surjit Dixit;Martin J.Boulanger;Thomas Spreter Von Kreudenstein;Eric Escobar-Cabrera;20222022, vol.14, no.1
Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological, and pathological disease in a Syrian hamster model of COVID-19Thomas J.Esparza;Yaozong Chen;Negin P.Martin;Helle Bielefeldt-Ohmann;Richard A.Bowen;William D.Tolbert;Marzena Pazgier;David L.Brody;20222022, vol.14, no.1
The human antibody sequence space and structural design of the V, J regions, and CDRH3 with RosettaSamuel Schmitz;Emily A.Schmitz;James E.Crowe Jr;Jens Meiler;20222022, vol.14, no.1
Machine learning prediction of antibody aggregation and viscosity for high concentration formulation development of protein therapeuticsPin-Kuang Lai;Austin Gallegos;Neil Mody;Hasige A.Sathish;Bernhardt L.Trout;20222022, vol.14, no.1
123456789